NeuClone’s Trastuzumab Trial Succeeds

Reports Successful Phase I Trial For NeuCeptin Trastuzumab Biosimilar

Compass_Success
NeuClone and partner Serum Institute of India have reported success in a phase I trial for trastuzumab • Source: Shutterstock

More from Biosimilars

More from Products